Skip to main content
Cureus logoLink to Cureus
. 2022 Dec 19;14(12):e32679. doi: 10.7759/cureus.32679

Parents' Knowledge of and Attitude Toward the Human Papillomavirus Vaccine in the Western Region of Saudi Arabia

Safa H Alkalash 1,2,, Faisal A Alshamrani 3, Ethar H Alhashmi Alamer 3, Ghaida M Alrabi 3, Faisal A Almazariqi 4, Hadeel M Shaynawy 4
Editors: Alexander Muacevic, John R Adler
PMCID: PMC9846376  PMID: 36660531

Abstract

Background: Human papillomavirus (HPV) is the most common cause of cervical cancer among Saudi females in reproductive age. Parents' awareness of and attitude toward vaccination against HPV in young females are very crucial to prevent the development of cervical cancer. This study aimed to assess the knowledge of and attitude toward the HPV vaccine among Saudi parents in the Saudi western region.

Methods: An analytical cross-sectional questionnaire-based study was conducted that included 343 parents randomly selected from in the Saudi western region. The online questionnaire was disseminated via WhatsApp and Telegram groups of parents in schools and among visitors of parents in primary health care.

Results: The studied parents had poor knowledge of HPV and its vaccine. About a third (32.9%) knew about the HPV vaccine and the most common source of their knowledge was physicians (38%) while the most frequent barrier for vaccination was their confidence of being not at risk (75.2%). About 90.0% of parents having a good level of knowledge were willing to vaccinate their children.

Conclusion: This study reveals a poor level of knowledge about HPV infection and its vaccine among both male and female parents in the Saudi Arabian western area. As a consequence, only 7.2% of them had vaccinated their female children. The majority of the parents having good knowledge about the HPV vaccine were willing to vaccinate their children. Therefore, this study highlights the necessity of educating women on cervical cancer risk factors, as well as the importance of screening programs.

Keywords: human papillomavirus (hpv), saudi parents, attitude, knowledge, hpv vaccine

Introduction

Human papillomaviruses (HPVs) are small, non-enveloped, icosahedral, double-stranded deoxyribonucleic acid (DNA) viruses with a diameter of 52-55 nm [1]. HPV is considered to be the most prevalent sexually transmitted disease (STD), affecting the cutaneous and mucosal epithelia [2]. Most subtypes of HPV do not result in any lesions, warts, or symptoms. They are referred to as non-oncogenic, or low-risk types, and are associated with genital warts, while others are referred to as oncogenic, or high-risk types, that can result in cancers or intraepithelial neoplasia [2-4]. HPV can cause cancers of the oropharynx, vagina, anus, and penis [2]. In addition, HPV is responsible for about 99% of cervical cancer cases associated with types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 68, 73, 82, 26, 53, and 66 [4,5]. Cervical cancer is the fourth most common cancer in women, and also, the fourth leading cause of cancer death among women worldwide [6].

According to Global Cancer Observatory database, there were 604,000 new cases and 342,000 deaths from cervical cancer worldwide in 2020. Also, variations in morbidity and mortality rates were seen geographically [7]. Additionally, it was found to be correlated with national income as determined by the World Bank, ranging from 16.1 instances per 100,000 person-years in low-income nations to 9.2 in lower-middle-income countries to 6.9 in high-income and upper-middle-income countries [8-12]. Globally, there were 13.1 new cases of cervical cancer per 100,000 women (assessed age-standardized incidence rate, or ASIR) [10].

Cervical cancer is ranked as the 13th most common malignancy in women in Saudi Arabia. In women between the ages of 15 and 44, cervical cancer is ranked as the sixth most prevalent cancer with an incidence rate of 1.9 incidents per 1000,000 women [8]. Saudi Arabia is regarded as one of the countries with the lowest incidence of cervical cancer associated with a low prevalence of HPV. Every year, there are 152 new instances of cervical cancer, and there are 55 cases of fatality [3]. Recent estimates showed that 6.51 million Saudi Arabian women aged 15 years or older are at a high risk of developing cervical cancer, according to the World Health Organization [9]. In most parts of the world, cervical cancer incidence and mortality rates have decreased during the past few decades [7].

The HPV vaccine reduces the risk of cervical cancer by 70% through primary prevention of HPV types 16 and 18, which are the high-risk kinds [5]. There are still challenges, such as sociodemographic factors (religion, education level, age, gender, employment/unemployment, and the number of children), cultural norms, and socioeconomic factors (lower income and education level corresponding to a lower HPV vaccine uptake) [2]. Parents decide whether or not to vaccinate their children against HPV, and this decision-making process is influenced by a number of variables. Individual attitudes, knowledge, and health behaviors are among these determinants, as are people's concerns about the vaccine's long-term safety and its negative effects [6].

The Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA) both recommended the HPV vaccine for both sexes in 2006. The HPV vaccine, which is typically given to females between the ages of 12 and 26 in three doses over the course of six months, has been effective as a primary preventative intervention against cervical cancer. Its use has been linked to a decrease in HPV-related illnesses, malignancies, and HPV genotype prevalence, with no documented negative effects [13,14]. The HPV vaccine has been accessible in the Kingdom of Saudi Arabia (KSA) for the past 10 years, and it is provided in major hospitals, with or without payment, to women with a doctor's prescription [14].

Parents' awareness about and attitude toward vaccines, like that for HPV, could affect their adherence to vaccinate their girls; hence, this study aimed to assess the knowledge and attitude of Saudi parents in the western region of Saudi Arabia toward the HPV vaccine.

Materials and methods

Study design and setting

An analytical cross-sectional questionnaire-based study was carried out among Saudi parents over a six-month period from June to November 2022. A pre-designed questionnaire based on previous studies was used to collect information regarding awareness and acceptance of the HPV vaccine among parents [15,16]. The study was conducted in the western region, including Madinah, Makkah, Jeddah, Al Qunfudah, Taif, and Al Ardiyat, of Saudi Arabia. An ethical approval was provided by the Medical Research and Ethical Committee of the College of Medicine, Umm Al-Qura University, Makkah (UQU reference FEGL260822). The confidentiality of the anonymously collected data was maintained all the time.

Pilot study

A pilot study of 35 participants was undertaken to check language clarity and question understandability; the survey was slightly amended prior to use to reflect the outcomes of the pilot trial. All data from this pilot study acted as a guidance for the study researchers, and was excluded from the main study results. Finally, the test-retest technique was used to ensure questionnaire reliability.

Study sample and procedure for data collection

A sample size of 343 was calculated using EPI InfoTM (CDC, Atlanta, GA) based on the size of the total population in the western region, which was 8,325,304, at a 95% CI and a 5% margin of error. Data were collected from a convenient sample of 343 Saudi parents by using an online questionnaire; a link to the survey was distributed to respondents, via WhatsApp groups, and Telegram groups of parents in schools, and was also distributed to visitors of parents in primary health care (PHC). The questionnaire consisted of three sections. The first section included items to collect data about participants' demographics (age, gender, marital status, educational level, employment, monthly income), and to inquire about having a female child. The second section assessed their knowledge about HPV and HPV vaccine that included nine questions; the last question asked whether the participant needed education about the human papillomavirus. The third section was to assess their attitude toward HPV vaccine, and willingness to vaccinate their female children with the HPV vaccine, and barriers for refusing vaccination, in addition to a question about previous children's HPV vaccination, and whether they had an access to the content of the children's vaccination book.

The number of total collected questionnaires was 366. Incomplete questionnaires (n = 23) were discarded, so the total number of valid and complete questionnaires was 343.

Data analysis

Data were statistically analysed using the IBM SPSS Statistics, version 26 (IBM Corp., Armonk, NY). Participants who had at least 80% correct answers were considered as having good knowledge while below 80% was considered a poor level of knowledge. Data analysis was further subdivided into a descriptive phase, where categorical variables were described using frequencies and percentages, and an analytical phase, where the relationship between the variables was demonstrated by Fisher's exact test and chi-squared test (χ2), which were applied to qualitative data. A P-value less than 0.05 was regarded as statistically significant.

Results

In our study, 39.1% of studied parents had an age ranging from 36 to 45 years; 66.2% were females and 86.3% were married (Table 1). Of them, 52.2% had university education and 67.9% were employed. Almost one third (33.8%) of the participants had a monthly income of 10,000-20,000 Saudi Riyals (SR) and 68.8% had a female child.

Table 1. Distribution of studied participants according to their demographics (N = 343).

SR, Saudi Riyals

All values are presented as numbers (N) and percentages (%).

Variable N Percentage
Age (years)
15-25 48 14.0
26-35 76 22.2
36-45 134 39.1
>45 85 24.8
Gender
Female 227 66.2
Male 116 33.8
Marital status
Widow 12 3.5
Married 296 86.3
Divorced 35 10.2
Education level
Intermediate school 58 16.9
Secondary school 18 5.2
Diploma 53 15.5
University 179 52.2
Postgraduate 35 10.2
Employment status
Employed 233 67.9
Unemployed 97 26.3
Student 13 3.8
Monthly income (SR)
<5000 48 14.0
5000-10,000 94 27.4
10,000-20,000 116 33.8
>20,000 26 7.6
None 59 17.2
Has a female child
No 107 31.2
Yes 236 68.8

A total of 34.7% parents had previous knowledge about HPV, 37.9% thought that HPV is very dangerous, and only 32.7% knew the harmful association between HPV infection and occurrence of cervix cancer (Table 2). The most common source of their knowledge was physicians (38.0%). A total of 19.2% thought that the vaccine has side effects, and 35.3% reported that it prevents HPV infection. The majority (87.8%) reported the need for education about HPV.

Table 2. Distribution of studied participants according to their response to knowledge items regarding HPV and HPV vaccine (N = 343).

HPV, human papillomavirus

All values are presented as numbers (N) and percentages (%).

Variable N Percentage
Has knowledge about HPV
No 224 65.3
Yes 119 34.7
HPV is very dangerous
No 32 9.3
Yes 130 37.9
Maybe 181 52.8
Harm that is associated with the infection with HPV
Cancer of the breast 1 0.3
Cancer of the anus, penis, vagina, vulva, and the back of the throat 1 0.3
Cancer of the cervix 112 32.7
Negatively affects fertility 25 7.3
Unknown 204 59.5
Has knowledge about the HPV vaccine
No 230 67.1
Yes 113 32.9
Source of knowledge about the HPV vaccine (N = 113)
Physicians 43 38.0
Internet 33 29.2
Family and friends 8 7.0
Social media 29 25.8
Vaccine has any side effects
No 73 21.3
Yes 66 19.2
Maybe 204 59.5
Vaccine prevents the infection with HPV
No 27 7.9
Yes 121 35.3
Maybe 195 56.9
Vaccine reduces the severity of symptoms after getting infected
No 33 9.6
Yes 165 48.1
Maybe 145 42.3
Target group for the vaccine
Unmarried females 9 to 25 years old 98 28.6
Married females 9 to 25 years old 37 10.8
Before marriage 22 6.4
Don't know 186 54.2
Facility that can introduce the HPV vaccine
Schools 2 0.6
Primary health care 133 38.8
Hospitals 42 12.2
Don't know 166 48.4
Need for more education about HPV
No 42 12.1
Yes 301 87.8

A total of 58.6% of studied parents were willing to vaccinate their children with the HPV vaccine (Table 3). For those who refused vaccination, the most common barrier was their thought of not being at risk of infection (75.2%). More than half of parents (59.5%) had a conviction about the effectiveness of the vaccine for their children, but only 7.2% had a child vaccinated against HPV.

Table 3. Distribution of studied participants according to their attitude toward and willingness to vaccinate their children with the HPV vaccine (N = 343).

HPV, human papillomavirus

All values are presented as numbers (N) and percentages (%).

Variable N Percentage
Willingness to vaccinate their children
No 52 15.2
Yes 201 58.6
Maybe 90 26.2
Reason for the refusal to vaccinate their children (N = 52)
Vaccine is expensive 0 0.0
Afraid of the side effect of the vaccine 1 1.9
Don't believe in the effectiveness of the vaccine 4 7.6
Don't have a family history for cervical cancer 1 1.9
Don't have enough knowledge about the vaccine 7 13.4
Not at risk to be affected 39 75.2
Conviction about the effectiveness of the vaccine for their children
No 45 13.1
Yes 204 59.5
Maybe 94 27.4
Have any of their children received the HPV vaccine (for those having a female child) (N = 236)
No 219 92.8
Yes 17 7.2
Have access to the content of their children's vaccination book
No 80 23.3
Yes 263 76.7

As shown in Figure 1, 94.2% of parents had a poor knowledge level regarding HPV and HPV vaccine, while 5.8% had a good knowledge level.

Figure 1. Percentage distribution of participants according to their knowledge level regarding HPV and HPV vaccine.

Figure 1

HPV, human papillomavirus

Employed parents, those who got their knowledge from physicians, who had access to the content of the children's vaccination book, and who had a conviction about the effectiveness of the vaccine for their children formed a significantly high percentage of those having a good knowledge level (P = 0.028, <0.001, 0.003, 0.011, 0.004; Table 4).

Table 4. Relationship between the knowledge level and participants' demographics (N = 343).

HPV, human papillomavirus; SR, Saudi Riyals

All values presented as numbers (N) and percentages (%).

*Statistically significant (P < 0.05).

Variable Knowledge level P-value
Poor Good
N Percentage N Percentage
Age (years) 0.269
15-25 46 14.2 2 10.0
26-35 73 22.6 3 15.0
36-45 122 37.8 12 60.0
>45 82 25.4 3 15.0
Gender 0.115
Female 217 67.2 10 50.0
Male 106 32.8 10 50.0
Marital status 0.542
Widow 12 3.7 0 0.0
Married 279 86.4 17 85.0
Divorced 32 9.9 3 15.0
Education level 0.124
Intermediate school 18 5.6 0 0.0
Secondary school 58 18.0 0 0.0
Diploma 49 15.2 4 20.0
University 167 51.7 12 60.0
Postgraduate 31 9.6 4 20.0
Employment status 0.028*
Employed 214 66.3 19 95.0
Unemployed 96 29.7 1 5.0
Student 13 4.0 0 0.0
Monthly income (SR) 0.166
<5000 47 14.6 1 5.0
5000-10,000 89 27.6 5 25.0
10,000-20,000 108 33.4 8 40.0
>20,000 22 6.8 4 20.0
None 57 17.6 2 10.0
Have female children 0.107
No 104 32.2 3 15.0
Yes 219 67.8 17 85.0
Source of knowledge about the HPV vaccine <0.001*
Physicians 30 9.3 13 65.0
Internet 29 9.0 4 20.0
Family and friends 8 2.5 0 0.0
Social media 26 8.0 3 15.0
Have any of their children received the HPV vaccine (for those having a female child) (N = 236) 0.003*
No 206 63.8 13 65.0
Yes 13 4.0 4 20.0
Have access to the content of their children's vaccination book 0.011*
No 80 24.8 0 0.0
Yes 243 75.2 20 100.0
Have a conviction about the effectiveness of the vaccine for their children 0.004*
No 45 13.9 0 0.0
Yes 185 57.3 19 95.0
Maybe 93 28.8 1 0.5

Married parents, who had university education, and who got their knowledge from physicians formed a significantly high percentage of those having a positive attitude and willing to vaccinate their children with the HPV vaccine (P = 0.011, 0.043, 0.001; Table 5).

Table 5. Relationship between participants' willing to vaccinate their children and their demographics (N = 343).

HPV, human papillomavirus; SR, Saudi Riyals

All values are presented as numbers (N) and percentages (%).

*Statistically significant (P < 0.05).

Variable Willing to vaccinate their children P-value
  Maybe No Yes  
N Percentage N Percentage N Percentage
Age (years) 0.079
15-25 10 11.1 6 11.5 32 15.9
26-35 15 16.7 11 21.2 50 24.9
36-45 43 47.8 15 28.8 76 37.8
>45 22 24.4 20 38.5 43 21.4
Gender 0.818
Female 62 68.9 34 65.4 131 65.2
Male 28 31.1 18 34.6 70 34.8
Marital status 0.011*
Widow 1 1.1 5 9.6 6 3.0
Married 74 82.2 42 80.8 180 89.6
Divorced 15 16.7 5 9.6 15 7.5
Education level 0.043*
Intermediate school 4 4.4 5 9.6 9 4.5
Secondary school 20 22.2 12 23.1 26 12.9
Diploma 10 11.1 2 3.8 41 20.4
University 48 53.3 28 53.8 103 51.2
Postgraduate 8 8.9 5 9.6 22 10.9
Employment status 0.709
Employed 57 63.3 34 65.4 142 70.6
Unemployed 30 33.3 16 30.8 51 25.4
Student 3 3.3 2 3.8 8 4.0
Monthly income (SR) 0.904
<5000 11 12.2 8 15.4 29 14.4
5000-10,000 22 24.4 13 25.0 59 29.4
10,000-20,000 34 37.8 20 38.5 62 30.8
>20,000 7 7.8 2 3.8 17 8.5
None 16 17.8 9 17.3 34 16.9
Has a female child 0.189
No 25 27.8 12 23.1 70 34.8
Yes 65 72.2 40 76.9 131 65.2
Source of knowledge about the HPV vaccine 0.001*
Physicians 5 5.6 5 9.6 33 16.4
Internet 1 1.1 4 7.7 28 13.9
Family and friends 3 3.3 1 1.9 4 2.0
Social media 6 6.7 2 3.8 21 10.4
Have any of their children received the HPV vaccine (for those having a female child) (N = 236) 0.057
No 64 71.1 38 73.1 117 58.2
Yes 1 1.1 2 3.8 14 7.0
Have access to the content of their children's vaccination book 0.952
No 20 22.2 12 23.1 48 23.9
Yes 70 77.8 40 76.9 153 76.1

As shown in Figure 2, parents who had a positive attitude and were willing to vaccinate their children with HPV formed a significantly high percentage of those with a good knowledge level (P = 0.021).

Figure 2. Relationship between the knowledge level and participants' attitude and willingness to vaccinate their children with the HPV vaccine (N = 343).

Figure 2

Fisher's exact test = 8.07, P = 0.021

Discussion

It has become critical to promote cervical cancer awareness in the Kingdom of Saudi Arabia because knowledge and awareness are important components when adopting healthy behaviors and accepting newly proposed preventative methods. According to the World Health Organization, HPV accounts for 99% of cervical cancer cases [17]. The HPV vaccine against the strains linked with cervical cancer has been on the market since 2006; nonetheless, much of the current data paints a picture of pervasive misunderstanding about HPV infection and vaccination among the target population [18]. Although there is a rising interest in community health awareness programs in Saudi Arabia, the majority of current researches focus on breast cancer, diabetes, and obesity. In contrast, only few studies with small sample sizes have been undertaken to examine Saudis' knowledge about cervical cancer, and uptake of HPV vaccination [19].

Participants in the current study, which covered the Saudi western region, had poor knowledge of HPV. The study found that 34.7% of parents had previous knowledge about HPV, 37.9% thought that HPV is very dangerous, and only 32.7% knew that the harm associated with HPV infection is cancer of the cervix. The cause for this poor level of knowledge regarding HPV and its vaccine may be that in KSA, the population usually knows only about the common compulsory vaccinations for their children, but not a new and unusual vaccine like HPV. Another cause for this poor knowledge, from our point of view, may be the insufficient health education from the side of primary health care. Therefore, it is recommended to increase public awareness about the HPV vaccine through encouraging their healthcare providers in primary care settings.

These findings are similar to a survey of 181 Saudi medical students done at King Faisal University in 2014, where the majority of the students had little understanding of early warning signs, symptoms, and risk factors for cervical cancer. The percentages of accurate answers varied from 43.7% to 55% on average [20]. Furthermore, the overall knowledge of cervical cancer among students aged 17 to 26 in Poland was found to be insufficient, and HPV infection was not thought to be the primary cause [21]. Surprisingly, a recent survey among healthcare practitioners in Greece revealed a considerable knowledge gap with HPV, with just 30% of the sample appearing to be aware of HPV playing a big part in carcinogenesis. According to the findings of a recent Thai poll, the level of understanding regarding HPV was quite low [22].

About a third of the current study participants (32.9%) had knowledge about the HPV vaccine; 19.2% of them thought that the vaccine had different side effects and the most common source of their knowledge was their physicians (38.0%). These results are the same as those obtained by a previous study in Saudi Arabia done in 2014, where 67% of the participants were unaware of the existence of HPV vaccination [20].

The majority of the current study subjects (87.8%) reported their need for health education about HPV. This is a very amenable issue because it reflects the readiness of public to improve their awareness level. Therefore, imparting community education is a mandatory action.

Moreover, this study found that 58.6% of parents were willing to vaccinate their children with the HPV vaccine, while 26.2% reported that they "may" vaccinate them. For those who refused vaccination, the most common barrier was their thought of not being at risk of infection (75.2%). More than half of parents (59.5%) had a conviction about the effectiveness of the vaccine for their children, but only 7.2% had a vaccinated child against HPV. Of them, 76.7% had access to the content of the children's vaccination book. These findings are congruent with those of a previous research done in Riyadh in 2016, in which only 37% of participants declined the immunization [23]. Furthermore, in a recent national research study conducted in Saudi Arabia, around 55% were eager to take the HPV vaccination if provided, and 73% said they would recommend the HPV vaccine to others. Similarly, over 50% of Jeddah medical students showed desire in obtaining the HPV vaccination [24,25].

Good knowledge about HPV vaccination was detected among employed parents, those who received health-related information from their physicians, who had already vaccinated their female children, who had access to the content of their children's vaccination book, and those who believed in the effectiveness of the vaccine for their children. This outcome was not unexpected as employed parents might hear about the new trend of the HPV vaccine from fellow workers, specifically after it becoming an obligatory vaccine requested by the intermediate schools to be given to all female students. In addition, parents who sought medical information from physicians had more accurate knowledge about the HPV vaccine than peers who received this information from a non-specialized source. Careful parents, who were keen to know about their children vaccination status through their vaccination books, were able to know more about the HPV vaccine that was added to the new schedule. Through explaining the indication and health benefits of any new drug or vaccine, it is easy to convince someone to get it. Therefore, parents who had a good level of knowledge about the vaccination became more convinced about its effectiveness.

It was noticed that being married, highly educated and receiving health information from the physicians were all determinants for willingness of the parents to vaccinate their children. This finding is a logical one as married, highly educated parents could know more and easily understand the health benefits of this vaccine, a vaccine that would protect their children from a highly aggressive disease such as cancer of the cervix. As a result, they would accept this vaccine more easily than others. Physicians are also able to persuade their patients, and clients, to receive the vaccine by explaining its health benefits and using evidence-based medicine.

At the end of this study, 90.0% of the parents, who had a good level of knowledge about the HPV vaccine, were found willing to vaccinate their children (P = 0.021). This result ensures the great necessity to conduct more health educational campaigns all over the Kingdom of Saudi Arabia, and not only in the western region, in order to raise public awareness about this highly important issue. Protection of women from cervical cancer starts by educating the whole population about it, and spreading awareness about its primary prevention, vaccination against HPV, which is already available within all regional PHC facilities.

This study also had some limitations. First, the obtained data about the number of vaccinated children was self-reported; thus, there is a possibility of measurement bias as self-reporting depends on memorizing capabilities of the participants and their education levels. Second, the online approach for data collection may threaten the credibility of the obtained data. Third, study results were compared with the statistics on HPV from few countries other than Saudi Arabia while it was better to compare the awareness level of the Saudi population with that from many other different countries in order to explore whether lack of awareness is significant or it is similar to trends elsewhere. Despite these limitations, this study had many strength points that have to be acknowledged. The most important one is that it highlighted the acceptability level of Saudi parents about the HPV vaccine and put a spotlight on their poor level of awareness and practice regarding such an important vaccine. The next benefit was that the study was conducted on a large scale in many different, big cities such as Jeddah, Makkah, Madinah, Taif, and Al Ardiyat in addition to Al Qunfudah, which is a remote area belonging to the Saudi western region. Opening the route for many other researches to be conducted in this area is one of the advantages of this research. Finally, attracting the attention of health institutions to provide community education courses on cervical cancer and how to avoid it through early detection and vaccination could be an advantage of this study.

Conclusions

This study reveals the poor level of knowledge about HPV infection and its vaccine among both male and female Saudi parents in the Saudi Arabian western area; even highly educated people claimed a lack of information. Health officials have recently begun promising nationwide HPV awareness initiatives to improve public understanding of HPV and the significance of vaccination. Therefore, through this study, we highlight the necessity of educating women about cervical cancer risk factors, as well as the importance of screening programs. Primary healthcare providers should provide knowledge about the HPV vaccine to their patients and clients, and encourage them to vaccinate their girls. A well-designed health education campaign regarding cervical cancer and the benefits of screening and immunization would increase public knowledge in Saudi Arabia.

Acknowledgments

The study researchers express their gratitude to all participants who contributed to the study.

The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.

The authors have declared that no competing interests exist.

Human Ethics

Consent was obtained or waived by all participants in this study. Medical Research and Ethical Committee, College of Medicine, Umm Al-Qura University, Makkah issued approval FEGL260822

Animal Ethics

Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue.

References

  • 1.Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer. Chelimo C, Wouldes TA, Cameron LD, Elwood JM. J Infect. 2013;66:207–217. doi: 10.1016/j.jinf.2012.10.024. [DOI] [PubMed] [Google Scholar]
  • 2.Correction: Parents' knowledge, beliefs, and acceptance of the HPV vaccination in relation to their socio-demographics and religious beliefs: a cross-sectional study in Thailand. Grandahl M, Paek SC, Grisurapong S, Sherer P, Tydén T, Lundberg P. PLoS One. 2018;13:0. doi: 10.1371/journal.pone.0193054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Clinical practice guidelines on the screening and treatment of precancerous lesions for cervical cancer prevention in Saudi Arabia. Al-Mandeel HM, Sagr E, Sait K, et al. Ann Saudi Med. 2016;36:313–320. doi: 10.5144/0256-4947.2016.313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Parents' knowledge and attitude towards HPV and HPV vaccination in Poland. Smolarczyk K, Duszewska A, Drozd S, Majewski S. Vaccines (Basel) 2022;10:228. doi: 10.3390/vaccines10020228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Characterization of human papillomavirus prevalence and risk factors to guide cervical cancer screening in the North Tongu District, Ghana. Krings A, Dunyo P, Pesic A, et al. PloS One. 2019;14:0. doi: 10.1371/journal.pone.0218762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Worldwide initiatives to eliminate cervical cancer. Wilailak S, Kengsakul M, Kehoe S. Int J Gynaecol Obstet. 2021;155:102–106. doi: 10.1002/ijgo.13879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. CA Cancer J Clin. 2021;71:209–249. doi: 10.3322/caac.21660. [DOI] [PubMed] [Google Scholar]
  • 8.Current studies on human papillomavirus in Saudi Arabia. Alhamlan FS, Al-Qahtani AA, Al-Ahdal MN. J Infect Dev Ctries. 2015;9:571–576. doi: 10.3855/jidc.6538. [DOI] [PubMed] [Google Scholar]
  • 9.Human papillomavirus vaccines: WHO position paper, May 2017-recommendations. World Health Organization. Vaccine. 2017;35:5753–5755. doi: 10.1016/j.vaccine.2017.05.069. [DOI] [PubMed] [Google Scholar]
  • 10.Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, Bray F. Lancet Glob Health. 2020;8:0–203. doi: 10.1016/S2214-109X(19)30482-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Cervical cancer in low and middle-income countries. Hull R, Mbele M, Makhafola T, et al. Oncol Lett. 2020;20:2058–2074. doi: 10.3892/ol.2020.11754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Lancet. 2020;8:0–90. doi: 10.1016/S2214-109X(19)30488-7. [DOI] [PubMed] [Google Scholar]
  • 13.Global burden of human papillomavirus and related diseases. Forman D, de Martel C, Lacey CJ, et al. Vaccine. 2012;30:0–23. doi: 10.1016/j.vaccine.2012.07.055. [DOI] [PubMed] [Google Scholar]
  • 14.Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies. Tota JE, Chevarie-Davis M, Richardson LA, Devries M, Franco EL. Prev Med. 2011;53:0–21. doi: 10.1016/j.ypmed.2011.08.017. [DOI] [PubMed] [Google Scholar]
  • 15.The vaccinaTion & Hpv Knowledge (THinK) questionnaire: a reliability and validity study on a sample of women living in Sicily (southern-Italy) Matranga D, Lumia C, Guarneri R, et al. PeerJ. 2019;7:0. doi: 10.7717/peerj.6254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Knowledge, attitude, and practice on and willingness to pay for human papillomavirus vaccine: a cross-sectional study in Hanoi, Vietnam. Tran BX, Than PT, Doan TT, et al. Patient Prefer Adherence. 2018;12:945–954. doi: 10.2147/PPA.S165357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Cervical cancer, human papillomavirus (HPV), and HPV vaccines. 2007. http://apps.who.int/iris/bitstream/handle/10665/69873/WHO_RHR_08.14_eng.pdf;jsessionid=1DF6A75B60253EA792CE06C7BE6CDD8A?sequence=1 http://apps.who.int/iris/bitstream/handle/10665/69873/WHO_RHR_08.14_eng.pdf;jsessionid=1DF6A75B60253EA792CE06C7BE6CDD8A?sequence=1
  • 18.Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP) Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. https://pubmed.ncbi.nlm.nih.gov/17380109/ MMWR Recomm Rep. 2007;56:1–24. [PubMed] [Google Scholar]
  • 19.Knowledge and acceptability of the HPV vaccine by school children and their parents in Birmingham. Das A, Madhwapathi V, Davies P, Brown G, Dearnley E, Spencer A, Williams H. Vaccine. 2010;28:1440–1446. doi: 10.1016/j.vaccine.2009.11.041. [DOI] [PubMed] [Google Scholar]
  • 20.Knowledge about cervical cancer early warning signs and symptoms, risk factors and vaccination among students at a medical school in Al-Ahsa, Kingdom of Saudi Arabia. Al-Darwish AA, Al-Naim AF, Al-Mulhim KS, Al-Otaibi NK, Morsi MS, Aleem AM. Asian Pac J Cancer Prev. 2014;15:2529–2532. doi: 10.7314/apjcp.2014.15.6.2529. [DOI] [PubMed] [Google Scholar]
  • 21.Knowledge, attitudes, and practices regarding cervical cancer screening among physicians in the Western Region of Saudi Arabia. Sait KH. https://pubmed.ncbi.nlm.nih.gov/22057604/ Saudi Med J. 2011;32:1155–1160. [PubMed] [Google Scholar]
  • 22.Cervical cancer screening in Kolkata, India: beliefs and predictors of cervical cancer screening among women attending a women's health clinic in Kolkata, India. Roy B, Tang TS. J Cancer Educ. 2008;23:253–259. doi: 10.1080/08858190802189105. [DOI] [PubMed] [Google Scholar]
  • 23.Attitudes and perceptions towards HPV vaccination among young women in Saudi Arabia. Hussain AN, Alkhenizan A, McWalter P, Qazi N, Alshmassi A, Farooqi S, Abdulkarim A. J Family Community Med. 2016;23:145–150. doi: 10.4103/2230-8229.189107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Attitudes, knowledge, and practices in relation to cervical cancer and its screening among women in Saudi Arabia. Sait KH. https://pubmed.ncbi.nlm.nih.gov/19750269/ Saudi Med J. 2009;30:1208–1212. [PubMed] [Google Scholar]
  • 25.Human papillomavirus knowledge and vaccine acceptability among male medical students in Saudi Arabia. Farsi NJ, Baharoon AH, Jiffri AE, Marzouki HZ, Merdad MA, Merdad LA. Hum Vaccin Immunother. 2021;17:1968–1974. doi: 10.1080/21645515.2020.1856597. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cureus are provided here courtesy of Cureus Inc.

RESOURCES